Considering that abnormal expression of these factors have been reported to be involved in various pathological conditions, including cancers [3, 19–21, 27, 28, 35], our findings supplied basic information for future investigating the roles of these eIF3 subunits in gliomas. Here, EIF3A is linked to central nervous system cancer.